Venturing into Longevity: Insights from Co-Founder and General Partner at Apollo Health Ventures, Ole Mensching, Ph. D., EN (#11)

In this week's episode we are excited to welcome Ole Mensching,
Ph. D., Co-Founder and General Partner at Apollo Health Ventures.





Apollo Health Ventures is a transatlantic early-stage Venture
Capital firm specialising in co-founding and investing in
healthcare companies targeting age-related diseases. They
actively participate in founding ventures, alongside investing in
best-in-class external opportunities.





This discussion explores the synergy between science and venture
capital, emphasising the role of artificial intelligence in
longevity. Apollo Health Ventures' distinct investment approach,
combining active co-founding and external opportunities, is
highlighted. Key factors like investment periods and ticket size
are discussed for their impact on venture success, considering
the delicate balance between risk and returns in longevity
investing. The conversation concludes with an outlook on the
future of longevity and the venture capital market, providing
insights into the evolving landscape of healthcare innovation and
investment.